動物用サプリメント市場(サプリメントタイプ:サプリメントタイプ:酸化防止剤、ビタミン、タンパク質/アミノ酸、酵素、プロバイオティクス、必須脂肪酸、その他;動物タイプ:コンパニオンアニマルおよび家畜)-世界産業分析、規模、シェア、成長、動向、予測、2023-2031年Veterinary Supplements Market (Supplement Type: Antioxidants, Vitamins, Proteins/Amino acids, Enzymes, Probiotics, Essential Fatty Acids, and Others; Animal Type: Companion Animals and Livestock) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031 動物用サプリメント市場 - レポートの範囲 TMR社の動物用サプリメントの世界市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー動物用サプリメント市場 - レポートの範囲TMR社の動物用サプリメントの世界市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界の動物用サプリメント市場の収益を提供しています。また、2023年から2031年までの世界の動物用サプリメント市場の複合年間成長率(CAGR %)も掲載しています。 本レポートは広範な調査を経て作成されています。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、動物用サプリメント市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照した。 二次調査には、インターネット情報源、政府機関の統計データ、ウェブサイト、業界団体も含まれる。アナリストは、世界の動物用サプリメント市場の様々な属性を調査するために、トップダウンアプローチとボトムアップアプローチの組み合わせを採用した。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、このレポートは、世界の動物用サプリメント市場における競争力学の変化に光を投げかけています。これらは、既存の市場プレーヤーだけでなく、世界の動物用サプリメント市場への参入に関心のある事業体にとっても貴重なツールとなります。 本レポートでは、世界の動物用サプリメント市場の競争環境について掘り下げています。世界の動物用サプリメント市場で事業を展開する主要企業が特定され、これらの各企業が様々な属性の観点からプロファイリングされている。会社概要、財務状況、最近の動向、SWOTは、このレポートで紹介されている世界の動物用サプリメント市場のプレーヤーの属性です。 世界の動物用サプリメント市場レポートで回答された主な質問 - 予測期間中、全地域で動物用サプリメントが生み出す売上/収益は? - 世界の動物用サプリメント市場における機会は何か? - 市場における主な促進要因、阻害要因、機会、脅威は何か? - 予測期間中に最も速いCAGRで拡大する地域市場はどこか? - 2031年に世界で最も高い収益を上げると予測されるセグメントは? - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは? - 世界市場で事業を展開する各企業の市場ポジションは? 動物用サプリメント市場 - 調査目的と調査アプローチ 世界の動物用サプリメント市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳細に説明しています。 本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴える。また、過去と予測期間末の主要セグメントの市場シェアを比較することもできる。 本レポートでは、世界の動物用サプリメント市場を製品、エンドユーザー、地域の観点から分析している。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載している。このような貴重な洞察は、市場関係者が世界の動物用サプリメント市場への投資のための情報に基づいたビジネス上の意思決定を行うことができます。 目次1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Veterinary Supplements Market 4. Market Overview 4.1. Introduction 4.1.1. Supplement Type Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Veterinary Supplements Market Analysis and Forecast, 2017-2031 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Insights on The impact of e-commerce on the pet sales landscape 5.2. U.S. pet ownership statistics 5.3. Regulatory Scenario by Region/Globally 5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact) 6. Global Veterinary Supplements Market Analysis and Forecast, by Supplement Type 6.1. Introduction & Definition 6.2. Key Findings/Developments 6.3. Market Value Forecast, by Supplement Type, 2017-2031 6.3.1. Antioxidants 6.3.2. Vitamins 6.3.3. Proteins/Amino acids 6.3.4. Enzymes 6.3.5. Probiotics 6.3.6. Essential Fatty Acids 6.3.7. Others 6.4. Market Attractiveness Analysis, by Supplement Type 7. Global Veterinary Supplements Market Analysis and Forecast, by Animal Type 7.1. Introduction & Definition 7.2. Key Findings/Developments 7.3. Market Value Forecast, by Animal Type, 2017-2031 7.3.1. Companion Animals 7.3.1.1. Dog 7.3.1.2. Cat 7.3.2. Livestock 7.3.2.1. Cattle 7.3.2.2. Horse 7.3.2.3. Sheep 7.3.3. Others 7.4. Market Attractiveness Analysis, by Animal Type 8. Global Veterinary Supplements Market Analysis and Forecast, by Application/Benefit Area 8.1. Introduction & Definition 8.2. Key Findings/Developments 8.3. Market Value Forecast, by Application/Benefit Area, 2017-2031 8.3.1. Joint Health Support 8.3.2. Calming/Stress/Anxiety 8.3.3. Digestive Health 8.3.4. Energy & Electrolytes 8.3.5. Immunity Support 8.3.6. Skin & Coat Health 8.3.7. Others 8.4. Market Attractiveness Analysis, by Application/Benefit Area 9. Global Veterinary Supplements Market Analysis and Forecast, by Dosage Form 9.1. Introduction & Definition 9.2. Key Findings/Developments 9.3. Market Value Forecast, by Dosage Form, 2017-2031 9.3.1. Pills & Tablets 9.3.2. Chewables 9.3.3. Powders 9.3.4. Others 9.4. Market Attractiveness Analysis, by Dosage Form 10. Global Veterinary Supplements Market Analysis and Forecast, by Distribution Channel 10.1. Introduction & Definition 10.2. Key Findings/Developments 10.3. Market Value Forecast, by Distribution Channel, 2017-2031 10.3.1. Small Animal Veterinary 10.3.2. Large Animal Veterinary 10.3.3. Mixed Animal Veterinary 10.3.4. Retail Stores 10.3.5. Drug Stores 10.3.6. Online Sales 10.4. Market Attractiveness Analysis, by Distribution Channel 11. Global Veterinary Supplements Market Analysis and Forecast, by Region 11.1. Key Findings 11.2. Market Value Forecast, by Region, 2017-2031 11.2.1. North America 11.2.2. Europe 11.2.3. Asia Pacific 11.2.4. Latin America 11.2.5. Middle East & Africa 11.3. Market Attractiveness Analysis, by Region 12. North America Veterinary Supplements Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Supplement Type, 2017-2031 12.2.1. Antioxidants 12.2.2. Vitamins 12.2.3. Proteins/Amino acids 12.2.4. Enzymes 12.2.5. Probiotics 12.2.6. Essential Fatty Acids 12.2.7. Others 12.3. Market Value Forecast, by Animal Type, 2017-2031 12.3.1. Companion Animals 12.3.1.1. Dog 12.3.1.2. Cat 12.3.2. Livestock 12.3.2.1. Cattle 12.3.2.2. Horse 12.3.2.3. Sheep 12.3.3. Others 12.4. Market Value Forecast, by Application/Benefit Area, 2017-2031 12.4.1. Joint Health Support 12.4.2. Calming/Stress/Anxiety 12.4.3. Digestive Health 12.4.4. Energy & Electrolytes 12.4.5. Immunity Support 12.4.6. Skin & Coat Health 12.4.7. Others 12.5. Market Value Forecast, by Dosage Form, 2017-2031 12.5.1. Pills & Tablets 12.5.2. Chewables 12.5.3. Powders 12.5.4. Others 12.6. Market Value Forecast, by Distribution Channel, 2017-2031 12.6.1. Small Animal Veterinary 12.6.2. Large Animal Veterinary 12.6.3. Mixed Animal Veterinary 12.6.4. Retail Stores 12.6.5. Drug Stores 12.6.6. Online Sales 12.7. Market Value Forecast, by Country, 2017-2031 12.7.1. U.S. 12.7.2. Canada 12.8. Market Attractiveness Analysis 12.8.1. By Supplement Type 12.8.2. By Animal Type 12.8.3. By Application/Benefit Area 12.8.4. By Dosage Form 12.8.5. By Distribution Channel 12.8.6. By Country 13. Europe Veterinary Supplements Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Supplement Type, 2017-2031 13.2.1. Antioxidants 13.2.2. Vitamins 13.2.3. Proteins/Amino acids 13.2.4. Enzymes 13.2.5. Probiotics 13.2.6. Essential Fatty Acids 13.2.7. Others 13.3. Market Value Forecast, by Animal Type, 2017-2031 13.3.1. Companion Animals 13.3.1.1. Dog 13.3.1.2. Cat 13.3.2. Livestock 13.3.2.1. Cattle 13.3.2.2. Horse 13.3.2.3. Sheep 13.3.3. Others 13.4. Market Value Forecast, by Application/Benefit Area, 2017-2031 13.4.1. Joint Health Support 13.4.2. Calming/Stress/Anxiety 13.4.3. Digestive Health 13.4.4. Energy & Electrolytes 13.4.5. Immunity Support 13.4.6. Skin & Coat Health 13.4.7. Others 13.5. Market Value Forecast, by Dosage Form, 2017-2031 13.5.1. Pills & Tablets 13.5.2. Chewables 13.5.3. Powders 13.5.4. Others 13.6. Market Value Forecast, by Distribution Channel, 2017-2031 13.6.1. Small Animal Veterinary 13.6.2. Large Animal Veterinary 13.6.3. Mixed Animal Veterinary 13.6.4. Retail Stores 13.6.5. Drug Stores 13.6.6. Online Sales 13.7. Market Value Forecast, by Country/Sub-region, 2017-2031 13.7.1. Germany 13.7.2. U.K. 13.7.3. France 13.7.4. Italy 13.7.5. Spain 13.7.6. Rest of Europe 13.8. Market Attractiveness Analysis 13.8.1. By Supplement Type 13.8.2. By Animal Type 13.8.3. By Application/Benefit Area 13.8.4. By Dosage Form 13.8.5. By Distribution Channel 13.8.6. By Country/Sub-region 14. Asia Pacific Veterinary Supplements Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Supplement Type, 2017-2031 14.2.1. Antioxidants 14.2.2. Vitamins 14.2.3. Proteins/Amino acids 14.2.4. Enzymes 14.2.5. Probiotics 14.2.6. Essential Fatty Acids 14.2.7. Others 14.3. Market Value Forecast, by Animal Type, 2017-2031 14.3.1. Companion Animals 14.3.1.1. Dog 14.3.1.2. Cat 14.3.2. Livestock 14.3.2.1. Cattle 14.3.2.2. Horse 14.3.2.3. Sheep 14.3.3. Others 14.4. Market Value Forecast, by Application/Benefit Area, 2017-2031 14.4.1. Joint Health Support 14.4.2. Calming/Stress/Anxiety 14.4.3. Digestive Health 14.4.4. Energy & Electrolytes 14.4.5. Immunity Support 14.4.6. Skin & Coat Health 14.4.7. Others 14.5. Market Value Forecast, by Dosage Form, 2017-2031 14.5.1. Pills & Tablets 14.5.2. Chewables 14.5.3. Powders 14.5.4. Others 14.6. Market Value Forecast, by Distribution Channel, 2017-2031 14.6.1. Small Animal Veterinary 14.6.2. Large Animal Veterinary 14.6.3. Mixed Animal Veterinary 14.6.4. Retail Stores 14.6.5. Drug Stores 14.6.6. Online Sales 14.7. Market Value Forecast, by Country/Sub-region, 2017-2031 14.7.1. China 14.7.2. Japan 14.7.3. India 14.7.4. Australia & New Zealand 14.7.5. Rest of Asia Pacific 14.8. Market Attractiveness Analysis 14.8.1. By Supplement Type 14.8.2. By Animal Type 14.8.3. By Application/Benefit Area 14.8.4. By Dosage Form 14.8.5. By Distribution Channel 14.8.6. By Country/Sub-region 15. Latin America Veterinary Supplements Market Analysis and Forecast 15.1. Introduction 15.1.1. Key Findings 15.2. Market Value Forecast, by Supplement Type, 2017-2031 15.2.1. Antioxidants 15.2.2. Vitamins 15.2.3. Proteins/Amino acids 15.2.4. Enzymes 15.2.5. Probiotics 15.2.6. Essential Fatty Acids 15.2.7. Others 15.3. Market Value Forecast, by Animal Type, 2017-2031 15.3.1. Companion Animals 15.3.1.1. Dog 15.3.1.2. Cat 15.3.2. Livestock 15.3.2.1. Cattle 15.3.2.2. Horse 15.3.2.3. Sheep 15.3.3. Others 15.4. Market Value Forecast, by Application/Benefit Area, 2017-2031 15.4.1. Joint Health Support 15.4.2. Calming/Stress/Anxiety 15.4.3. Digestive Health 15.4.4. Energy & Electrolytes 15.4.5. Immunity Support 15.4.6. Skin & Coat Health 15.4.7. Others 15.5. Market Value Forecast, by Dosage Form, 2017-2031 15.5.1. Pills & Tablets 15.5.2. Chewables 15.5.3. Powders 15.5.4. Others 15.6. Market Value Forecast, by Distribution Channel, 2017-2031 15.6.1. Small Animal Veterinary 15.6.2. Large Animal Veterinary 15.6.3. Mixed Animal Veterinary 15.6.4. Retail Stores 15.6.5. Drug Stores 15.6.6. Online Sales 15.7. Market Value Forecast, by Country/Sub-region, 2017-2031 15.7.1. Brazil 15.7.2. Mexico 15.7.3. Rest of Latin America 15.8. Market Attractiveness Analysis 15.8.1. By Supplement Type 15.8.2. By Animal Type 15.8.3. By Application/Benefit Area 15.8.4. By Dosage Form 15.8.5. By Distribution Channel 15.8.6. By Country/Sub-region 16. Middle East & Africa Veterinary Supplements Market Analysis and Forecast 16.1. Introduction 16.1.1. Key Findings 16.2. Market Value Forecast, by Supplement Type, 2017-2031 16.2.1. Antioxidants 16.2.2. Vitamins 16.2.3. Proteins/Amino acids 16.2.4. Enzymes 16.2.5. Probiotics 16.2.6. Essential Fatty Acids 16.2.7. Others 16.3. Market Value Forecast, by Animal Type, 2017-2031 16.3.1. Companion Animals 16.3.1.1. Dog 16.3.1.2. Cat 16.3.2. Livestock 16.3.2.1. Cattle 16.3.2.2. Horse 16.3.2.3. Sheep 16.3.3. Others 16.4. Market Value Forecast, by Application/Benefit Area, 2017-2031 16.4.1. Joint Health Support 16.4.2. Calming/Stress/Anxiety 16.4.3. Digestive Health 16.4.4. Energy & Electrolytes 16.4.5. Immunity Support 16.4.6. Skin & Coat Health 16.4.7. Others 16.5. Market Value Forecast, by Dosage Form, 2017-2031 16.5.1. Pills & Tablets 16.5.2. Chewables 16.5.3. Powders 16.5.4. Others 16.6. Market Value Forecast, by Distribution Channel, 2017-2031 16.6.1. Small Animal Veterinary 16.6.2. Large Animal Veterinary 16.6.3. Mixed Animal Veterinary 16.6.4. Retail Stores 16.6.5. Drug Stores 16.6.6. Online Sales 16.7. Market Value Forecast, by Country/Sub-region, 2017-2031 16.7.1. GCC Countries 16.7.2. South Africa 16.7.3. Rest of Middle East & Africa 16.8. Market Attractiveness Analysis 16.8.1. By Supplement Type 16.8.2. By Animal Type 16.8.3. By Application/Benefit Area 16.8.4. By Dosage Form 16.8.5. By Distribution Channel 16.8.6. By Country/Sub-region 17. Competition Landscape 17.1. Market Player - Competition Matrix (by tier and size of companies) 17.2. Market Share Analysis, by Company, 2022 17.3. Company Profiles 17.3.1. Zoetis 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.1.2. Product Portfolio 17.3.1.3. Financial Overview 17.3.1.4. SWOT Analysis 17.3.1.5. Strategic Overview 17.3.2. Ceva Sante Animale 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2.2. Product Portfolio 17.3.2.3. Financial Overview 17.3.2.4. SWOT Analysis 17.3.2.5. Strategic Overview 17.3.3. Elanco Animal Health 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.3.2. Product Portfolio 17.3.3.3. Financial Overview 17.3.3.4. SWOT Analysis 17.3.3.5. Strategic Overview 17.3.4. Vetoquinol S.A. 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.4.2. Product Portfolio 17.3.4.3. Financial Overview 17.3.4.4. SWOT Analysis 17.3.4.5. Strategic Overview 17.3.5. Dechra Pharmaceuticals plc 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.5.2. Product Portfolio 17.3.5.3. Financial Overview 17.3.5.4. SWOT Analysis 17.3.5.5. Strategic Overview 17.3.6. Merck Animal Health 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.6.2. Product Portfolio 17.3.6.3. Financial Overview 17.3.6.4. SWOT Analysis 17.3.6.5. Strategic Overview 17.3.7. Virbac S.A. 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.7.2. Product Portfolio 17.3.7.3. Financial Overview 17.3.7.4. SWOT Analysis 17.3.7.5. Strategic Overview 17.3.8. Boehringer Ingelheim 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.8.2. Product Portfolio 17.3.8.3. Financial Overview 17.3.8.4. SWOT Analysis 17.3.8.5. Strategic Overview 17.3.9. Norbrook Laboratories Limited 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.9.2. Product Portfolio 17.3.9.3. Financial Overview 17.3.9.4. SWOT Analysis 17.3.9.5. Strategic Overview 17.3.10. Hester Biosciences Limited 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.10.2. Product Portfolio 17.3.10.3. Financial Overview 17.3.10.4. SWOT Analysis 17.3.10.5. Strategic Overview 17.3.11. Merial Animal Health Limited 17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.11.2. Product Portfolio 17.3.11.3. Financial Overview 17.3.11.4. SWOT Analysis 17.3.11.5. Strategic Overview 17.3.12. Novartis Animal Health, Inc. 17.3.12.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.12.2. Product Portfolio 17.3.12.3. Financial Overview 17.3.12.4. SWOT Analysis 17.3.12.5. Strategic Overview 17.3.13. Nutreco N.V. 17.3.13.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.13.2. Product Portfolio 17.3.13.3. Financial Overview 17.3.13.4. SWOT Analysis 17.3.13.5. Strategic Overview 17.3.14. Ouro Fino Saúde Animal 17.3.14.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.14.2. Product Portfolio 17.3.14.3. Financial Overview 17.3.14.4. SWOT Analysis 17.3.14.5. Strategic Overview
SummaryVeterinary Supplements Market – Scope of Report Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Veterinary Supplements Market 4. Market Overview 4.1. Introduction 4.1.1. Supplement Type Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Veterinary Supplements Market Analysis and Forecast, 2017-2031 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Insights on The impact of e-commerce on the pet sales landscape 5.2. U.S. pet ownership statistics 5.3. Regulatory Scenario by Region/Globally 5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact) 6. Global Veterinary Supplements Market Analysis and Forecast, by Supplement Type 6.1. Introduction & Definition 6.2. Key Findings/Developments 6.3. Market Value Forecast, by Supplement Type, 2017-2031 6.3.1. Antioxidants 6.3.2. Vitamins 6.3.3. Proteins/Amino acids 6.3.4. Enzymes 6.3.5. Probiotics 6.3.6. Essential Fatty Acids 6.3.7. Others 6.4. Market Attractiveness Analysis, by Supplement Type 7. Global Veterinary Supplements Market Analysis and Forecast, by Animal Type 7.1. Introduction & Definition 7.2. Key Findings/Developments 7.3. Market Value Forecast, by Animal Type, 2017-2031 7.3.1. Companion Animals 7.3.1.1. Dog 7.3.1.2. Cat 7.3.2. Livestock 7.3.2.1. Cattle 7.3.2.2. Horse 7.3.2.3. Sheep 7.3.3. Others 7.4. Market Attractiveness Analysis, by Animal Type 8. Global Veterinary Supplements Market Analysis and Forecast, by Application/Benefit Area 8.1. Introduction & Definition 8.2. Key Findings/Developments 8.3. Market Value Forecast, by Application/Benefit Area, 2017-2031 8.3.1. Joint Health Support 8.3.2. Calming/Stress/Anxiety 8.3.3. Digestive Health 8.3.4. Energy & Electrolytes 8.3.5. Immunity Support 8.3.6. Skin & Coat Health 8.3.7. Others 8.4. Market Attractiveness Analysis, by Application/Benefit Area 9. Global Veterinary Supplements Market Analysis and Forecast, by Dosage Form 9.1. Introduction & Definition 9.2. Key Findings/Developments 9.3. Market Value Forecast, by Dosage Form, 2017-2031 9.3.1. Pills & Tablets 9.3.2. Chewables 9.3.3. Powders 9.3.4. Others 9.4. Market Attractiveness Analysis, by Dosage Form 10. Global Veterinary Supplements Market Analysis and Forecast, by Distribution Channel 10.1. Introduction & Definition 10.2. Key Findings/Developments 10.3. Market Value Forecast, by Distribution Channel, 2017-2031 10.3.1. Small Animal Veterinary 10.3.2. Large Animal Veterinary 10.3.3. Mixed Animal Veterinary 10.3.4. Retail Stores 10.3.5. Drug Stores 10.3.6. Online Sales 10.4. Market Attractiveness Analysis, by Distribution Channel 11. Global Veterinary Supplements Market Analysis and Forecast, by Region 11.1. Key Findings 11.2. Market Value Forecast, by Region, 2017-2031 11.2.1. North America 11.2.2. Europe 11.2.3. Asia Pacific 11.2.4. Latin America 11.2.5. Middle East & Africa 11.3. Market Attractiveness Analysis, by Region 12. North America Veterinary Supplements Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Supplement Type, 2017-2031 12.2.1. Antioxidants 12.2.2. Vitamins 12.2.3. Proteins/Amino acids 12.2.4. Enzymes 12.2.5. Probiotics 12.2.6. Essential Fatty Acids 12.2.7. Others 12.3. Market Value Forecast, by Animal Type, 2017-2031 12.3.1. Companion Animals 12.3.1.1. Dog 12.3.1.2. Cat 12.3.2. Livestock 12.3.2.1. Cattle 12.3.2.2. Horse 12.3.2.3. Sheep 12.3.3. Others 12.4. Market Value Forecast, by Application/Benefit Area, 2017-2031 12.4.1. Joint Health Support 12.4.2. Calming/Stress/Anxiety 12.4.3. Digestive Health 12.4.4. Energy & Electrolytes 12.4.5. Immunity Support 12.4.6. Skin & Coat Health 12.4.7. Others 12.5. Market Value Forecast, by Dosage Form, 2017-2031 12.5.1. Pills & Tablets 12.5.2. Chewables 12.5.3. Powders 12.5.4. Others 12.6. Market Value Forecast, by Distribution Channel, 2017-2031 12.6.1. Small Animal Veterinary 12.6.2. Large Animal Veterinary 12.6.3. Mixed Animal Veterinary 12.6.4. Retail Stores 12.6.5. Drug Stores 12.6.6. Online Sales 12.7. Market Value Forecast, by Country, 2017-2031 12.7.1. U.S. 12.7.2. Canada 12.8. Market Attractiveness Analysis 12.8.1. By Supplement Type 12.8.2. By Animal Type 12.8.3. By Application/Benefit Area 12.8.4. By Dosage Form 12.8.5. By Distribution Channel 12.8.6. By Country 13. Europe Veterinary Supplements Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Supplement Type, 2017-2031 13.2.1. Antioxidants 13.2.2. Vitamins 13.2.3. Proteins/Amino acids 13.2.4. Enzymes 13.2.5. Probiotics 13.2.6. Essential Fatty Acids 13.2.7. Others 13.3. Market Value Forecast, by Animal Type, 2017-2031 13.3.1. Companion Animals 13.3.1.1. Dog 13.3.1.2. Cat 13.3.2. Livestock 13.3.2.1. Cattle 13.3.2.2. Horse 13.3.2.3. Sheep 13.3.3. Others 13.4. Market Value Forecast, by Application/Benefit Area, 2017-2031 13.4.1. Joint Health Support 13.4.2. Calming/Stress/Anxiety 13.4.3. Digestive Health 13.4.4. Energy & Electrolytes 13.4.5. Immunity Support 13.4.6. Skin & Coat Health 13.4.7. Others 13.5. Market Value Forecast, by Dosage Form, 2017-2031 13.5.1. Pills & Tablets 13.5.2. Chewables 13.5.3. Powders 13.5.4. Others 13.6. Market Value Forecast, by Distribution Channel, 2017-2031 13.6.1. Small Animal Veterinary 13.6.2. Large Animal Veterinary 13.6.3. Mixed Animal Veterinary 13.6.4. Retail Stores 13.6.5. Drug Stores 13.6.6. Online Sales 13.7. Market Value Forecast, by Country/Sub-region, 2017-2031 13.7.1. Germany 13.7.2. U.K. 13.7.3. France 13.7.4. Italy 13.7.5. Spain 13.7.6. Rest of Europe 13.8. Market Attractiveness Analysis 13.8.1. By Supplement Type 13.8.2. By Animal Type 13.8.3. By Application/Benefit Area 13.8.4. By Dosage Form 13.8.5. By Distribution Channel 13.8.6. By Country/Sub-region 14. Asia Pacific Veterinary Supplements Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Supplement Type, 2017-2031 14.2.1. Antioxidants 14.2.2. Vitamins 14.2.3. Proteins/Amino acids 14.2.4. Enzymes 14.2.5. Probiotics 14.2.6. Essential Fatty Acids 14.2.7. Others 14.3. Market Value Forecast, by Animal Type, 2017-2031 14.3.1. Companion Animals 14.3.1.1. Dog 14.3.1.2. Cat 14.3.2. Livestock 14.3.2.1. Cattle 14.3.2.2. Horse 14.3.2.3. Sheep 14.3.3. Others 14.4. Market Value Forecast, by Application/Benefit Area, 2017-2031 14.4.1. Joint Health Support 14.4.2. Calming/Stress/Anxiety 14.4.3. Digestive Health 14.4.4. Energy & Electrolytes 14.4.5. Immunity Support 14.4.6. Skin & Coat Health 14.4.7. Others 14.5. Market Value Forecast, by Dosage Form, 2017-2031 14.5.1. Pills & Tablets 14.5.2. Chewables 14.5.3. Powders 14.5.4. Others 14.6. Market Value Forecast, by Distribution Channel, 2017-2031 14.6.1. Small Animal Veterinary 14.6.2. Large Animal Veterinary 14.6.3. Mixed Animal Veterinary 14.6.4. Retail Stores 14.6.5. Drug Stores 14.6.6. Online Sales 14.7. Market Value Forecast, by Country/Sub-region, 2017-2031 14.7.1. China 14.7.2. Japan 14.7.3. India 14.7.4. Australia & New Zealand 14.7.5. Rest of Asia Pacific 14.8. Market Attractiveness Analysis 14.8.1. By Supplement Type 14.8.2. By Animal Type 14.8.3. By Application/Benefit Area 14.8.4. By Dosage Form 14.8.5. By Distribution Channel 14.8.6. By Country/Sub-region 15. Latin America Veterinary Supplements Market Analysis and Forecast 15.1. Introduction 15.1.1. Key Findings 15.2. Market Value Forecast, by Supplement Type, 2017-2031 15.2.1. Antioxidants 15.2.2. Vitamins 15.2.3. Proteins/Amino acids 15.2.4. Enzymes 15.2.5. Probiotics 15.2.6. Essential Fatty Acids 15.2.7. Others 15.3. Market Value Forecast, by Animal Type, 2017-2031 15.3.1. Companion Animals 15.3.1.1. Dog 15.3.1.2. Cat 15.3.2. Livestock 15.3.2.1. Cattle 15.3.2.2. Horse 15.3.2.3. Sheep 15.3.3. Others 15.4. Market Value Forecast, by Application/Benefit Area, 2017-2031 15.4.1. Joint Health Support 15.4.2. Calming/Stress/Anxiety 15.4.3. Digestive Health 15.4.4. Energy & Electrolytes 15.4.5. Immunity Support 15.4.6. Skin & Coat Health 15.4.7. Others 15.5. Market Value Forecast, by Dosage Form, 2017-2031 15.5.1. Pills & Tablets 15.5.2. Chewables 15.5.3. Powders 15.5.4. Others 15.6. Market Value Forecast, by Distribution Channel, 2017-2031 15.6.1. Small Animal Veterinary 15.6.2. Large Animal Veterinary 15.6.3. Mixed Animal Veterinary 15.6.4. Retail Stores 15.6.5. Drug Stores 15.6.6. Online Sales 15.7. Market Value Forecast, by Country/Sub-region, 2017-2031 15.7.1. Brazil 15.7.2. Mexico 15.7.3. Rest of Latin America 15.8. Market Attractiveness Analysis 15.8.1. By Supplement Type 15.8.2. By Animal Type 15.8.3. By Application/Benefit Area 15.8.4. By Dosage Form 15.8.5. By Distribution Channel 15.8.6. By Country/Sub-region 16. Middle East & Africa Veterinary Supplements Market Analysis and Forecast 16.1. Introduction 16.1.1. Key Findings 16.2. Market Value Forecast, by Supplement Type, 2017-2031 16.2.1. Antioxidants 16.2.2. Vitamins 16.2.3. Proteins/Amino acids 16.2.4. Enzymes 16.2.5. Probiotics 16.2.6. Essential Fatty Acids 16.2.7. Others 16.3. Market Value Forecast, by Animal Type, 2017-2031 16.3.1. Companion Animals 16.3.1.1. Dog 16.3.1.2. Cat 16.3.2. Livestock 16.3.2.1. Cattle 16.3.2.2. Horse 16.3.2.3. Sheep 16.3.3. Others 16.4. Market Value Forecast, by Application/Benefit Area, 2017-2031 16.4.1. Joint Health Support 16.4.2. Calming/Stress/Anxiety 16.4.3. Digestive Health 16.4.4. Energy & Electrolytes 16.4.5. Immunity Support 16.4.6. Skin & Coat Health 16.4.7. Others 16.5. Market Value Forecast, by Dosage Form, 2017-2031 16.5.1. Pills & Tablets 16.5.2. Chewables 16.5.3. Powders 16.5.4. Others 16.6. Market Value Forecast, by Distribution Channel, 2017-2031 16.6.1. Small Animal Veterinary 16.6.2. Large Animal Veterinary 16.6.3. Mixed Animal Veterinary 16.6.4. Retail Stores 16.6.5. Drug Stores 16.6.6. Online Sales 16.7. Market Value Forecast, by Country/Sub-region, 2017-2031 16.7.1. GCC Countries 16.7.2. South Africa 16.7.3. Rest of Middle East & Africa 16.8. Market Attractiveness Analysis 16.8.1. By Supplement Type 16.8.2. By Animal Type 16.8.3. By Application/Benefit Area 16.8.4. By Dosage Form 16.8.5. By Distribution Channel 16.8.6. By Country/Sub-region 17. Competition Landscape 17.1. Market Player - Competition Matrix (by tier and size of companies) 17.2. Market Share Analysis, by Company, 2022 17.3. Company Profiles 17.3.1. Zoetis 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.1.2. Product Portfolio 17.3.1.3. Financial Overview 17.3.1.4. SWOT Analysis 17.3.1.5. Strategic Overview 17.3.2. Ceva Sante Animale 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2.2. Product Portfolio 17.3.2.3. Financial Overview 17.3.2.4. SWOT Analysis 17.3.2.5. Strategic Overview 17.3.3. Elanco Animal Health 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.3.2. Product Portfolio 17.3.3.3. Financial Overview 17.3.3.4. SWOT Analysis 17.3.3.5. Strategic Overview 17.3.4. Vetoquinol S.A. 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.4.2. Product Portfolio 17.3.4.3. Financial Overview 17.3.4.4. SWOT Analysis 17.3.4.5. Strategic Overview 17.3.5. Dechra Pharmaceuticals plc 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.5.2. Product Portfolio 17.3.5.3. Financial Overview 17.3.5.4. SWOT Analysis 17.3.5.5. Strategic Overview 17.3.6. Merck Animal Health 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.6.2. Product Portfolio 17.3.6.3. Financial Overview 17.3.6.4. SWOT Analysis 17.3.6.5. Strategic Overview 17.3.7. Virbac S.A. 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.7.2. Product Portfolio 17.3.7.3. Financial Overview 17.3.7.4. SWOT Analysis 17.3.7.5. Strategic Overview 17.3.8. Boehringer Ingelheim 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.8.2. Product Portfolio 17.3.8.3. Financial Overview 17.3.8.4. SWOT Analysis 17.3.8.5. Strategic Overview 17.3.9. Norbrook Laboratories Limited 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.9.2. Product Portfolio 17.3.9.3. Financial Overview 17.3.9.4. SWOT Analysis 17.3.9.5. Strategic Overview 17.3.10. Hester Biosciences Limited 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.10.2. Product Portfolio 17.3.10.3. Financial Overview 17.3.10.4. SWOT Analysis 17.3.10.5. Strategic Overview 17.3.11. Merial Animal Health Limited 17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.11.2. Product Portfolio 17.3.11.3. Financial Overview 17.3.11.4. SWOT Analysis 17.3.11.5. Strategic Overview 17.3.12. Novartis Animal Health, Inc. 17.3.12.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.12.2. Product Portfolio 17.3.12.3. Financial Overview 17.3.12.4. SWOT Analysis 17.3.12.5. Strategic Overview 17.3.13. Nutreco N.V. 17.3.13.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.13.2. Product Portfolio 17.3.13.3. Financial Overview 17.3.13.4. SWOT Analysis 17.3.13.5. Strategic Overview 17.3.14. Ouro Fino Saúde Animal 17.3.14.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.14.2. Product Portfolio 17.3.14.3. Financial Overview 17.3.14.4. SWOT Analysis 17.3.14.5. Strategic Overview
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポートTransparency Market Research社の製薬分野での最新刊レポート
本レポートと同じKEY WORD(enzymes)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |